MARKET

AXGN

AXGN

Axogen Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.91
-0.11
-0.95%
After Hours: 11.19 +0.29 +2.61% 17:05 07/10 EDT
OPEN
10.99
PREV CLOSE
11.01
HIGH
10.99
LOW
10.57
VOLUME
240.99K
TURNOVER
--
52 WEEK HIGH
22.10
52 WEEK LOW
7.16
MARKET CAP
433.60M
P/E (TTM)
-15.4571
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AXGN stock price target is 15.50 with a high estimate of 21.00 and a low estimate of 12.00.

EPS

AXGN News

More
Is AxoGen, Inc. (AXGN) Going to Burn These Hedge Funds?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter
Insider Monkey · 3d ago
Axogen Announces New Seven-Year Financing Agreement with Oberland Capital and Provides Preliminary Second Quarter Revenue Estimate
GlobeNewswire · 07/01 12:00
Axogen initiates new seven-year financing agreement with Oberland Capital
Seeking Alpha - Article · 07/01 11:28
Axogen Sees Prelim. Q2 Sales $21M+, Down 21% YoY
Benzinga · 07/01 11:02
Axogen Announces New Up To $75M Seven-Year Financing Agreement with Oberland Capital
Summary Financing agreement provides up to $75.0 million in three tranches with interest only payments over seven years $35.0 million drawn by the Company upon closing the agreement on June 30, 2020
Benzinga · 07/01 11:02
Edited Transcript of AXGN.OQ earnings conference call or presentation 6-May-20 8:30pm GMT
Thomson Reuters StreetEvents · 06/23 14:46
Axogen, Inc. Announces Planned Retirement of Greg Freitag and Appoints Brad Ottinger as General Counsel and Chief Compliance Officer
GlobeNewswire · 06/01 12:00
96 Biggest Movers From Yesterday
Gainers Mmtec, Inc. (NASDAQ: MTC) shares climbed 86.4% to close at $2.05 on Tuesday after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797, in 2019.
Benzinga · 05/27 08:20

Industry

Advanced Medical Equipment & Technology
-0.60%
Healthcare Equipment & Supplies
-0.31%

Hot Stocks

Symbol
Price
%Change

About AXGN

AxoGen, Inc. offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane. Along with these core surgical products, the Company also offers the AxoTouch Two-Point Discriminator, and AcroVal Neurosensory and Motor Testing System. These evaluation and measurement tools assist healthcare professionals in detecting changes in sensation; assessing return of sensory, grip and pinch function; evaluating treatment interventions, and providing feedback to patients on nerve function. Its portfolio of products is available in the United States, Canada, the United Kingdom and several European and other countries. The Company's products are used by surgeons during surgical interventions to repair a range of nerve injuries throughout the body.
More

Webull offers kinds of AxoGen Inc stock information, including NASDAQ:AXGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXGN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AXGN stock methods without spending real money on the virtual paper trading platform.